Innovation and the Opioid Crisis

A $40B+ industry in the US alone. Big Fines for Big Pharma, emerging policy and new “Addiction Tech” on a mission to change the paradigm for the treatment of pain.

Health Intelligence Unit

calendar image
May 5, 2022

The treatment of drug, alcohol and other substance addictions in the US alone is estimated to be a $40B+ industry that is being targeted by a range of tech innovators looking to disrupt a sector struggling to cope with the spiraling opioid crisis.

Digital health firms are adopting a variety of business models to shake up this relatively unreformed market, including; telehealth, remote prescribing, digital cognitive behavior therapy, peer support networks and audiovisual sensory treatments. In the 12 months to April 2021 deaths from drug overdoses passed 100k in the US, a 28.5% increase on the same period the year before.

Customers can read the full analyst note on-platform. Not a customer yet? Request a demo of HolonIQ’s market intelligence platform.

No items found.
No items found.
No items found.

Latest Insights

Global Insights from HolonIQ’s Intelligence Unit. Powered by our Global Impact Intelligence Platform.

Sign Up for our Newsletters

We provide you with relevant and up-to-date insights on the global impact economy. Choose out of our newsletters and you will find trending topics in your inbox.

Weekly Newsletter

Climate Technology

Weekly Newsletter

Education Technology

Weekly Newsletter

Health Technology

Weekly Newsletter

Higher Education

Daily Newsletter

Chart of the Day

Daily Newsletter

Impact Capital Markets